Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Diagnosing musculoskeletal tumours.

Grimer RJ, Carter SR, Spooner D, Sneath RS.

Sarcoma. 2001;5(2):89-94. doi: 10.1155/S1357714X01000172.

2.

Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern.

de Vreeze RS, de Jong D, Haas RL, Stewart F, van Coevorden F.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1480-7. doi: 10.1016/j.ijrobp.2008.03.008. Epub 2008 Apr 28.

PMID:
18448271
3.

The effect of an unplanned excision of a soft-tissue sarcoma on prognosis.

Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A.

J Bone Joint Surg Br. 2008 Feb;90(2):203-8. doi: 10.1302/0301-620X.90B2.19760.

PMID:
18256089
4.

Metastatic myxoid liposarcomas: imaging and histopathologic findings.

Sheah K, Ouellette HA, Torriani M, Nielsen GP, Kattapuram S, Bredella MA.

Skeletal Radiol. 2008 Mar;37(3):251-8. Epub 2007 Dec 21.

PMID:
18097662
5.

Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.

Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Benjamin RS, Pollock RE.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):760-5. Epub 2007 Sep 24.

PMID:
17892916
6.

Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology.

Engström K, Bergh P, Cederlund CG, Hultborn R, Willen H, Aman P, Kindblom LG, Meis-Kindblom JM.

Acta Oncol. 2007;46(6):838-45.

PMID:
17653909
8.

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.

Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, Sanfilippo R, Casieri P, Collini P, Dileo P, Spreafico C, Stacchiotti S, Tamborini E, Tercero JC, Jimeno J, D'Incalci M, Gronchi A, Fletcher JA, Pilotti S, Casali PG.

Lancet Oncol. 2007 Jul;8(7):595-602.

PMID:
17586092
9.

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG, Gronchi A.

Cancer. 2007 Jun 15;109(12):2522-31.

10.

Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread.

Schwab JH, Boland P, Guo T, Brennan MF, Singer S, Healey JH, Antonescu CR.

Ann Surg Oncol. 2007 Apr;14(4):1507-14. Epub 2007 Jan 26.

PMID:
17252290
11.

Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.

ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E, Suurmeijer AJ.

Ann Surg Oncol. 2007 Jan;14(1):222-9. Epub 2006 Oct 22.

PMID:
17058128
12.

Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.

Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S.

Ann Surg. 2006 Sep;244(3):381-91.

13.

Differential sensitivity of liposarcoma subtypes to chemotherapy.

Jones RL, Fisher C, Al-Muderis O, Judson IR.

Eur J Cancer. 2005 Dec;41(18):2853-60. Epub 2005 Nov 10.

PMID:
16289617
14.

Metastatic myxoid liposarcoma: aggressive multimodality management.

Prestwich RJ, Taylor RE, Grimer R.

Clin Oncol (R Coll Radiol). 2005 Apr;17(2):130. No abstract available.

PMID:
15830582
15.

Radiation response: an additional unique signature of myxoid liposarcoma.

Pitson G, Robinson P, Wilke D, Kandel RA, White L, Griffin AM, Bell RS, Catton CN, Wunder JS, O'Sullivan B.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):522-6.

PMID:
15380587
16.

Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.

Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL.

Cancer. 2003 May 15;97(10):2530-43.

17.

Metastatic patterns of extremity myxoid liposarcoma and their outcome.

Estourgie SH, Nielsen GP, Ott MJ.

J Surg Oncol. 2002 Jun;80(2):89-93.

PMID:
12173385
18.

Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence.

Gerrand CH, Wunder JS, Kandel RA, O'Sullivan B, Catton CN, Bell RS, Griffin AM, Davis AM.

J Bone Joint Surg Br. 2001 Nov;83(8):1149-55.

19.

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M.

Clin Cancer Res. 2001 Dec;7(12):3977-87.

20.

Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.

Meis-Kindblom JM, Sjögren H, Kindblom LG, Peydró-Mellquist A, Röijer E, Aman P, Stenman G.

Virchows Arch. 2001 Aug;439(2):141-51.

PMID:
11561754
Items per page

Supplemental Content

Write to the Help Desk